Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Still Expects Axonics Deal To Close This Year, Posts Street Beating Q3 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific acquires urology company Axonics for $3.7 billion
Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly. Read More
Boston Scientific closes $3.7B Axonics deal after lengthy review
Boston Scientific officially closed its multibillion-dollar acquisition of Axonics roughly 10 months after announcing the proposal. The deal is valued at $71 per share, representing $3.7 billion ... Read More
Axonics gains after Nasdaq delisting notice for sale to Boston Scientific
Axonics (NASDAQ:AXNX) quickly edged higher by 0.8% after a Nasdaq delisting notice for its planned sale to Boston Scientific (BSX). The deal is tentatively scheduled to close prior to the market ... Read More
Boston Scientific closes acquisition of Axonics - Nasdaq
Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an equity value of $3.7B and an enterprise value of $3.3B. Read More
Axonics gains after Boston Scientific says it will end use of ... - MSN
Axonics (NASDAQ:AXNX) quickly rose 1% after Boston Scientific (BSX) said it will no longer offer Coaptite as of Nov. 1. Investors believe the announcement may mean that Boston Scientific (BSX ... Read More
Boston Scientific Stock Set to Gain From Completion of Axonics Deal
In the past year, Boston Scientific shares have surged 66.1% compared with the industry’s growth of 21.4%. BSX’s Zacks Rank and Key Picks. Boston Scientific currently carries a Zacks Rank #3 ... Read More
Boston Scientific Corporation: Boston Scientific Closes Acquisition of ...
MARLBOROUGH, Mass., Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: Anzeige ... Read More
Boston Scientific posts 177% EP growth, pauses Farapulse study
Boston Scientific was also able to close its $1.26 billion deal for Silk Road Medical and its carotid artery vascularization procedure, but it is still waiting to finalize its acquisition of Axonics. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus